Blastomycosis Treatment Market Share

APAC Market Statistics

The Asian Pacific blastomycosis treatment market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2036. The growth of the market can be attributed to rising malnutrition and unsanitary conditions in this region. For instance, India continues to have one of the highest rates of child malnutrition worldwide. Malnutrition may result from an energy shortfall or a lack of certain micronutrients, it alters the immune system in several ways by raising virus sensitivity and suppressing immunological responses. Poor immunity as a result makes a person more susceptible to illnesses such as blastomycosis, which in turn is expected lead to an increase in demand for treatments of such illnesses in the region. In addition, the region's expanding healthcare industry and economic growth are also anticipated to boost the market growth during the forecast period. Over 3 million children in India are undernourished, with more than half of them classified as seriously undernourished.

North American Market Forecast

The North American blastomycosis treatment market, amongst the market in all the other regions, is projected to grow with the highest CAGR during the forecast period. The growth of the market can be attributed majorly to the increased frequency of various fungal infections including blastomycosis. For instance, the majority of instances take place in Canada and the US. Moreover, Wisconsin possibly has the highest prevalence of blastomycosis of any state, which has increased the need for treatment in the region. Further, these fungi have spread more widely throughout the United States as a result of several causes, such as travel-related exposure, anthropogenic climate change, and changing land development methods. In addition, the increasing concern towards health is also anticipated to boost the market growth during the forecast period. According to the statistics provided by the U.S. Centers for Disease Control and Prevention (CDC), the prevalence of blastomycosis varies by location and can reach over 20 cases per 100,000 people in various areas of the United States.

Europe Market Forecast

Further, the market in Europe, amongst the market in all the other regions, is projected to hold a majority of the share by the end of 2036. The growth of the market can be attributed majorly to the increasingly sedentary lifestyle of individuals in this region. For instance, the EU has a high prevalence of sedentary lifestyles, which is mostly owing to the rising consumption of unhealthy foods. Consumption of unhealthy food leads to various nutritional deficiencies in the body. Moreover, the deficiency may impair the immune system, increasing the risk of blastomycosis among the local population, which is anticipated to boost market growth during the forecast period in this region.